Convalescent plasma in patients hospitalised with COVID-19-Reference-Cited by-同舟云学术

Convalescent plasma in patients hospitalised with COVID-19

Published:2021-05 Issue:10289 Volume:397 Page:2024-2025
ISSN:0140-6736
Container-title:The Lancet
language:en
Short-container-title:The Lancet

Author:

Liu Sean T H,Aberg Judith A

Funder

Gilead Sciences

Janssen Pharmaceuticals

Pfizer

Merck

Publisher

Elsevier BV

Subject

General Medicine

Reference11 articles.

1. Convalescent plasma antibody levels and the risk of death from Covid-19;Joyner;N Engl J Med,2021

2. Convalescent plasma treatment of severe COVID-19: a propensity score-matched control study;Liu;Nat Med,2020

3. Treatment of COVID-19 patients with convalescent plasma;Salazar;Am J Pathol,2020

4. Convalescent plasma in the management of moderate covid-19 in adults in India: open label phase II multicentre randomised controlled trial (PLACID Trial);Agarwal;BMJ,2020

5. A randomized trial of convalescent plasma in Covid-19 severe pneumonia;Simonovich;N Engl J Med,2021

Cited by 20 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Evaluation of the therapeutic action of original antiviral drug in SARS‐CoV‐2;Biotechnology and Applied Biochemistry;2024-05-06

2. Multivalent bicyclic peptides are an effective antiviral modality that can potently inhibit SARS-CoV-2;Nature Communications;2023-06-16

3. UDCA, a novel strategy for preventing SARS-CoV-2 infection via FXR-mediated ACE2 downregulation;Acta Biochimica et Biophysica Sinica;2023-04-20

4. Safety, Tolerability, and Pharmacokinetics of Anti-SARS-CoV-2 Immunoglobulin Intravenous (Human) Investigational Product (COVID-HIGIV) in Healthy Adults: a Randomized, Controlled, Double-Blinded, Phase 1 Study;Antimicrobial Agents and Chemotherapy;2023-02-28

5. Age-dependent blood signatures of rehabilitated patients with mild COVID-19;2023-01-11